Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TPST Tempest Therapeutics Inc.

交易中 03-24 12:32:11 EDT

1.76

-0.08

-4.34%

最高1.85	最低1.75	成交量7.60万
今开1.83	昨收1.84	日振幅5.43%
总市值2,373万	流通市值1,520万	总股本1,348万
成交额13.58万	换手率0.88%	流通股本863.74万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TPST","market":"US","secType":"STK","nameCN":"Tempest Therapeutics Inc.","latestPrice":1.7601,"timestamp":1774368547507,"preClose":1.84,"halted":0,"volume":75951,"delay":0,"changeRate":-0.043423913043478306,"floatShares":8637400,"shares":13481099,"eps":-10.103,"marketStatus":"交易中","change":-0.0799,"latestTime":"03-24 12:32:11 EDT","open":1.83,"high":1.8499,"low":1.75,"amount":135816.1402374,"amplitude":0.054293,"askPrice":1.79,"askSize":58,"bidPrice":1.76,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-10.103,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.84,"preHourTrading":{"tag":"盘前","latestPrice":1.85,"preClose":1.84,"latestTime":"09:24 EDT","volume":8495,"amount":15851.328501,"timestamp":1774358640107,"change":0.01,"changeRate":0.005435,"amplitude":0.027174},"postHourTrading":{"tag":"盘后","latestPrice":1.85,"preClose":1.84,"latestTime":"19:55 EDT","volume":5297,"amount":9765.5948,"timestamp":1774310145786,"change":0.01,"changeRate":0.005435,"amplitude":0.014837},"volumeRatio":0.968327,"impliedVol":1.4125,"impliedVolPercentile":0.25},"requestUrl":"/m/hq/s/TPST","defaultTab":"news","newsList":[{"id":"1124401307","title":"Tempest宣布Tpst-2003合作计划，为2026年美国注册研究铺路","url":"https://stock-news.laohu8.com/highlight/detail?id=1124401307","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124401307?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:03","pubTimestamp":1773230591,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. (简称Tempest) 近日披露了一项关于其核心候选药物Tpst-2003的战略合作。这一重要举措旨在为2026年在美国启动的注册性研究做好充分准备。合作将整合多方资源，加速该药物的临床开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"1171963738","title":"Tempest Therapeutics：公司同时探索将TPST-2003的潜在开发范围扩展至LBCL患者及其他相关适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1171963738","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171963738?lang=zh_cn&edition=full","pubTime":"2026-02-25 21:02","pubTimestamp":1772024532,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. 正在积极拓展其研发管线，公司目前正探索将核心候选药物TPST-2003的潜在开发计划延伸至淋巴瘤B细胞淋巴瘤（LBCL）患者群体，并覆盖其他相关适应症。这一战略动向显示出公司致力于挖掘该疗法在更广泛疾病领域中的应用潜力，旨在为更多患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"1175464319","title":"Tempest Therapeutics Inc - 签署1.2百万普通股以每股3.625美元的购买与销售的最终协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1175464319","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175464319?lang=zh_cn&edition=full","pubTime":"2025-11-25 21:05","pubTimestamp":1764075910,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc - 签署1.2百万普通股以每股3.625美元的购买与销售的最终协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"1196395799","title":"Tempest宣布最多835万美元的普通股注册直接发行及按市场价格同时进行的权证私人配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1196395799","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196395799?lang=zh_cn&edition=full","pubTime":"2025-11-25 21:00","pubTimestamp":1764075647,"startTime":"0","endTime":"0","summary":"Tempest宣布最多835万美元的普通股注册直接发行及按市场价格同时进行的权证私人配售","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"1183063688","title":"Tempest Therapeutics第三季度每股收益为-0.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183063688","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183063688?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:43","pubTimestamp":1763570594,"startTime":"0","endTime":"0","summary":"11月5日——Tempest Therapeutics Inc.报告第三季度每股收益为-0.79美元；第三季度净收入为-351.1万美元；第三季度营业收入为-359.7万美元。进一步公司信息请参见TPST.O。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"1111949857","title":"Tempest Therapeutics Inc: 计划在2027年开始在美国进行Rrmm的潜在注册研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1111949857","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111949857?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:03","pubTimestamp":1763561023,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc: 计划在2027年开始在美国进行Rrmm的潜在注册研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"1158040409","title":"Tempest Therapeutics Inc. - 将向Factor关联公司发行8,268,495股，占已发行股份的65%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158040409","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158040409?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:02","pubTimestamp":1763560937,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. - 将向Factor关联公司发行8,268,495股，占已发行股份的65%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"1169342078","title":"Tempest宣布从Factor战略收购新的双车T程序，同时预计在2027年中进行跑道扩展","url":"https://stock-news.laohu8.com/highlight/detail?id=1169342078","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169342078?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:01","pubTimestamp":1763560901,"startTime":"0","endTime":"0","summary":"Tempest宣布从Factor战略收购新的双车T程序，同时预计在2027年中进行跑道扩展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"1184969833","title":"Tempest Therapeutics Inc.：Stephen Brady 在收购完成后将担任董事会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=1184969833","media":"美股速递","labels":["executive","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184969833?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:01","pubTimestamp":1763560891,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc.：Stephen Brady 在收购完成后将担任董事会主席","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2517923710","title":"Tempest Therapeutics, Inc.盘中异动 下午盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517923710?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:27","pubTimestamp":1741202872,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时27分，Tempest Therapeutics, Inc.股票出现异动，股价大幅上涨5.22%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.05%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032752abea042e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032752abea042e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TPST"],"gpt_icon":0},{"id":"2514033299","title":"Tempest Therapeutics, Inc.盘中异动 快速下挫5.65%报0.781美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514033299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514033299?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:22","pubTimestamp":1740687755,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时22分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.65%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1923.81%、370.28%、193.42%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280422369895504d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280422369895504d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"gpt_icon":0},{"id":"2513217948","title":"Tempest Therapeutics, Inc.盘中异动 急速下跌5.06%报0.861美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513217948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513217948?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:59","pubTimestamp":1740171553,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时59分，Tempest Therapeutics, Inc.股票出现波动，股价急速下跌5.06%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222045913abd7fddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222045913abd7fddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST","BK4139"],"gpt_icon":0},{"id":"2511578140","title":"Tempest Therapeutics, Inc.盘中异动 大幅上涨5.10%报0.944美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511578140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511578140?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:20","pubTimestamp":1739467238,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日01时20分，Tempest Therapeutics, Inc.股票出现异动，股价快速上涨5.10%。截至发稿，该股报0.944美元/股，成交量74.1309万股，换手率1.70%，振幅4.76%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214012039a244ce2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214012039a244ce2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TPST"],"gpt_icon":0},{"id":"2510865671","title":"Tempest Therapeutics, Inc.盘中异动 早盘大幅拉升6.12%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510865671?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197882,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Tempest Therapeutics, Inc.股票出现波动，股价快速上涨6.12%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223122a240a1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223122a240a1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"gpt_icon":0},{"id":"2508141356","title":"Tempest Therapeutics, Inc.盘中异动 早盘快速下挫5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141356?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593151,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.85%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322323298796f1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322323298796f1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"gpt_icon":0},{"id":"2506574582","title":"Tempest Therapeutics, Inc.盘中异动 临近收盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506574582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506574582?lang=zh_cn&edition=full","pubTime":"2025-01-28 04:36","pubTimestamp":1738010218,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日04时36分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.03%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804365896126de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804365896126de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","LENZ","BK4139"],"gpt_icon":0},{"id":"2503964206","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503964206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503964206?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951590,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Tempest Therapeutics, Inc.股票出现异动，股价急速下挫5.32%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Allovir, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.52%、56.84%、35.49%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522331098673ba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522331098673ba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","LENZ","BK4139"],"gpt_icon":0},{"id":"2503884275","title":"Tempest Therapeutics, Inc.盘中异动 早盘大幅下挫5.02%报0.902美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503884275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503884275?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778730,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.02%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2741.64%、1797.61%、390.72%，振幅较大的相关个股有Exicure, Inc.、Verrica制药、Champions Oncology, Inc.，振幅分别为110.04%、106.80%、101.18%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223210a2203f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223210a2203f05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"gpt_icon":0},{"id":"2494945384","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大跌5.26%报0.837美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494945384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494945384?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:22","pubTimestamp":1735312923,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时22分，Tempest Therapeutics, Inc.股票出现波动，股价快速跳水5.26%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232203a20c0948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232203a20c0948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","LENZ","BK4139"],"gpt_icon":0},{"id":"2493576415","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493576415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493576415?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:40","pubTimestamp":1734964825,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时40分，Tempest Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322402895eadbcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322402895eadbcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tempesttx.com","stockEarnings":[{"period":"1week","weight":-0.1674},{"period":"1month","weight":-0.2333},{"period":"3month","weight":-0.3947},{"period":"6month","weight":-0.8},{"period":"1year","weight":-0.8278},{"period":"ytd","weight":-0.3589}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tempest Therapeutics Inc成立于2011年4月5日。该公司是一家临床阶段的肿瘤学公司，专注于利用对癌症生物学和药物化学的深刻科学理解，开发和推进用于治疗实体瘤的新型口服疗法。该公司正在推进两个候选产品TPST-1120和TPST-1495的临床试验，它们被认为是第一个被设计用于抑制各自靶点的临床阶段分子；以及两个临床前项目，其中一个可能是第一个靶向TREX-1的项目，TREX-1是一种调节肿瘤先天免疫反应的关键细胞酶。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.012727},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.032927},{"month":3,"riseRate":0.461538,"avgChangeRate":0.007365},{"month":4,"riseRate":0.25,"avgChangeRate":-0.140205},{"month":5,"riseRate":0.461538,"avgChangeRate":0.004949},{"month":6,"riseRate":0.307692,"avgChangeRate":-0.113246},{"month":7,"riseRate":0.230769,"avgChangeRate":-0.025247},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.054209},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.059229},{"month":10,"riseRate":0.461538,"avgChangeRate":0.94597},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.081423},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.062561}],"exchange":"NASDAQ","name":"Tempest Therapeutics Inc.","nameEN":"Tempest Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tempest Therapeutics Inc.(TPST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tempest Therapeutics Inc.,TPST,Tempest Therapeutics Inc.股票,Tempest Therapeutics Inc.股票老虎,Tempest Therapeutics Inc.股票老虎国际,Tempest Therapeutics Inc.行情,Tempest Therapeutics Inc.股票行情,Tempest Therapeutics Inc.股价,Tempest Therapeutics Inc.股市,Tempest Therapeutics Inc.股票价格,Tempest Therapeutics Inc.股票交易,Tempest Therapeutics Inc.股票购买,Tempest Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tempest Therapeutics Inc.(TPST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}